Opus Genetics, Inc.·4

Mar 17, 8:56 PM ET

SCHACHLE JOSEPH K 4

4 · Opus Genetics, Inc. · Filed Mar 17, 2025

Insider Transaction Report

Form 4
Period: 2025-03-13
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-03-13+52,50054,500 total
  • Award

    Employee Stock Option (right to buy)

    2025-03-13+52,50052,500 total
    Exercise: $0.93Exp: 2035-03-12Common Stock (52,500 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
  • [F2]The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Documents

1 file
  • 4
    form4.xmlPrimary